Related Experiment Video

Updated: Aug 25, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
10:12

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

Published on: August 8, 2013

Current concepts in standardization of cardiac marker immunoassays

Mauro Panteghini1

  • 1Laboratorio Analisi Chimico Cliniche 1, Azienda Ospedaliera "Spedali Civili", 25125 Brescia, Italy. panteghi@bshosp.osp.unibs.it

Clinical Chemistry and Laboratory Medicine
|April 6, 2004
PubMed

Insights

Standardizing cardiac marker immunoassays is crucial for accurate patient data interpretation. Current methods lack standardization, necessitating the development of reference materials and procedures for reliable cardiac marker measurements.

Area of Science:

  • Clinical Chemistry
  • Immunoassay Technology
  • Biomarker Standardization

Background:

  • Cardiac markers are vital for diagnosing heart conditions.
  • Current immunoassay methods for cardiac markers lack standardization, leading to variable results.
  • Interpreting patient data is challenging due to assay inconsistencies.

Purpose of the Study:

  • To discuss the challenges in standardizing cardiac marker immunoassays.
  • To explore concepts for implementing a metrologically sound measurement system.
  • To provide practical examples for cardiac marker immunoassay standardization.

Main Methods:

  • Review of current immunoassay methodologies for cardiac markers.
  • Discussion of metrological principles for measurement systems.
  • Analysis of existing standardization initiatives (e.g., IFCC).

Main Results:

  • Significant variability exists between different cardiac marker assays.
  • Absence of certified reference materials hinders accurate quantification.
  • Cardiac troponins in patient blood differ from newly synthesized proteins, complicating standardization.

Conclusions:

  • Cardiac marker standardization is a complex, long-term challenge.
  • Development of reference procedures and certified reference materials is essential.
  • Implementing metrologically correct systems is key to improving assay reliability and data interpretation.

More Related Videos

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method09:32

Procedure and Key Optimization Strategies for an Automated Capillary Electrophoretic-based Immunoassay Method

Published on: September 10, 2017

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes13:42

Measurement of Antibody Effects on Cellular Function of Isolated Cardiomyocytes

Published on: March 8, 2013

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Enzyme-Linked Immunosorbent Assay01:33

Enzyme-Linked Immunosorbent Assay

In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen.  Enzyme-substrate reaction allows the antigen to be visualized or quantified.
Immunogold Electron Microscopy01:20

Immunogold Electron Microscopy

Immunoelectron microscopy utilizes immunogold labeling of endogenous proteins with specific antibodies to detect and localize these proteins in cells and tissues. The procedure provides insights into the distribution and quantification of protein under different stimulation conditions offering clues about their functions. Conjugating highly electron-dense gold particles with primary or secondary antibodies allow antigen detection on and within cells, with high resolution and specificity.
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...